INTRODUCTION
Suspected neonatal sepsis, or sepsis syndrome in the term infant, is the most common diagnosis for admission to Neonatal Intensive Care Units (NICU) in the United States. 1 While prematurity appropriately constitutes a major focus of care in the NICU, the volume of term admissions for suspected sepsis occurs five to 10 times more often than admissions of premature neonates. 1 Consequently, the patient days that infants with suspected sepsis contribute to health care costs represent a significant component of reimbursement in the NICU. Since very few of these infants subsequently have positive blood cultures, it is important to define if prolonged treatment of these infants is justified, and, as importantly, whether variations in practice approach among neonatologists add unnecessarily to length of stay and the cost of care.
The most common presentation for infants with presumed sepsis occurs when a mother has a fever or develops apparent chorioamnionitis during labor and delivery, especially when the Group B Streptococcal (GBS) status is not known. In many instances, babies born to GBS-positive mothers without fever are also admitted and treated with antibiotics in the NICU. As a result of the legitimate concern with respect to GBS disease in these situations, the Centers for Disease Control has recommended that ''if the result of GBS culture is not known at the onset of labor, intrapartum chemoprophylaxis should be administered to women with any of the following risk factors: gestation <37 weeks, duration of membrane rupture Z18 hours, or a temperature of Z100.41F (Z38.01C).'' 2 The recommendations further indicate, however, that ''routine use of antimicrobial prophylaxis for newborns whose mothers received intrapartum chemoprophylaxis for GBS infection is not recommended,'' and that ''a healthy appearing infant whose mother received Z4 hours of intrapartum prophylaxis may be discharged home after 24 hours if other discharge criteria have been met and a person able to comply fully with instructions for home observation is available.'' 2 Lastly, the CDC recommends that if ''laboratory results and clinical course do not indicate bacterial infection, duration [of therapy] may be as short as 48 hours'' in the infant. 2 Nevertheless, many neonatologists treat these infants for a significantly longer period of time, even with negative cultures, an unremarkable complete blood count (CBC), or a low acute phase reactant studies [e.g., C-reactive protein (RP)], in neonates who appear completely well. It appears that there is often substantial variation in practice for suspected sepsis among neonatologists in the same hospital, as well as among neonatologists in different regions of the country.
The purpose of this study, therefore, is to define the variability in practice of neonatologists in the United States with respect to the management of suspected neonatal sepsis, or sepsis syndrome. The intent is to provide information that might safely reduce the duration of hospital stay for infants with this diagnosis and diminish the overall cost of care.
METHODS
All neonates (N ¼ 998) with a diagnosis of suspected sepsis that had management oversight by a national neonatal care management company (ParadigmHealth, Concord, CA, formerly Paidos Health Management Services) between January 1, 2001 and December 31, 2002 were evaluated. Paradigm provides neonatal case management for a variety of insurance companies in numerous hospitals throughout the country. Neonatal nurses, who functioned as patient managers for the care management company, performed on-site data entry for these infants concurrent with their hospitalization. All patient information was entered into the ParadigmHealth clinical database, known as PROACT r . The database also was designed with numerous crosscheck algorithms to be sure that data was entered accurately; cases could not be ''closed'' unless certain criteria were fulfilled as required by the database.
The 998 infants represented all patients in the PROACT r database with an admitting diagnosis of suspected neonatal sepsis during the 2 years of the study period. All infants included in the data analysis had a birth weight greater than 2500 g and were term gestation, defined as 37 weeks or greater at delivery by best obstetrical estimate or by Ballard score if the former was unavailable. Infants were excluded if they had any major congenital anomalies or required surgical intervention. All infants included in this study were in room air and had begun normal oral feedings by 24 hours of life. No patient had a positive blood, urine, or cerebrospinal fluid culture. All infants were asymptomatic by 24 hours of life as noted in their hospital records, and the discharge timing in each case was determined by their primary physician. Outcome variables that were examined included five potential maternal risk factors for sepsis, as documented in the neonatal record. These factors included the following: premature rupture of membranes (PROM) >18 hours; maternal fever; chorioamnionitis; maternal cultures positive for GBS prior to delivery; and administration of antibiotics to the mother during labor and delivery. Infants were evaluated by examining the number of maternal risk factors for neonatal sepsis and the subsequent duration of antibiotic therapy between 1 and 10 days of life. The patients were divided into two groups for comparison purposes: infants who had maternal risk factors for sepsis that were documented at delivery and infants with no observable maternal risk factors for sepsis. In the group with no observed maternal risk factors, patients were treated with antibiotics for indications such as early transient tachypnea, meconium-stained amniotic fluid, decreased Apgar scores at birth, or regurgitation of an initial feeding, among others. In the second group, babies were treated primarily for the maternal indications, though they also may have had transient early neonatal symptoms that lasted less than 24 hours. Both groups were examined for duration of antibiotic therapy and length of hospital stay.
Five regions of the country with sufficient numbers of patients in the PROACT r database with this diagnosis were also evaluated for possible regional practice differences. Prior publications utilizing this database had demonstrated clinical practice variability among neonatologists. 3, 4 The regions were not identified in the analysis of the data because of potential HIPAA concerns that might arise if the sites were disclosed. These regions were examined for both duration of antibiotic therapy and length of stay for infants in the presence or absence of maternal risk factors.
All values are expressed as mean±standard deviation. The Student's t-test was used to compare infants in each category by number of days treated. A w 2 test was applied to examine whether any differences existed in patients treated for more or less than 3 days. Regional differences were compared using one-way analysis of variance (ANOVA). Significant differences were defined by a p-value <0.05.
All data were evaluated with no patient identifiers and analyses were therefore completely HIPAA compliant at an individual patient level.
RESULTS
In all, 998 term infants with an admitting diagnosis of possible neonatal sepsis met criteria for study inclusion. The mean birth weight for this group was 3470.6±547.5 (SD) g, and the mean gestational age was 39.3±1.2 weeks. Of these patients, 488 (48.9%) had none of the documented maternal risk factors for sepsis at the time of delivery. These infants received antimicrobial therapy, as previously noted, because of some other perceived factor that might be related to sepsis. In the infants with documented maternal risk factors, 259 (26%) were born to mothers known to be GBS positive, 282 mothers (28.3%) received intrapartum antibiotics, 81 mothers (8.1%) were diagnosed with clinical chorioamnionitis, and 84 (8.4%) of the pregnancies had PROM. Maternal fever, another risk factor, was present simultaneously in many of these categories. There were no statistical differences noted in birth weights or gestational ages among infants with or without maternal risk factors for sepsis. Table 1 demonstrates the number of patients observed with zero, one, or two or more maternal risk factors for sepsis at the time of delivery. Mean duration of antibiotic use and mean length of stay is also indicated. There were no differences noted in the duration of antibiotic use in any of the three categories listed. Increased numbers of maternal risk factors were not associated with more frequent use of antibiotics or a longer period of therapy.
The duration of antibiotic treatment ranged from 1 to 10 days and is shown in Table 2 . The majority of infants were treated for 3 days or less in both the risk (70.4%) and nonrisk (72.3%) suspected sepsis groups. There were no statistical differences, however, in the duration of treatment duration with respect to maternal risk factors. Of note is the fact that 286 infants (28.7%) were treated with antibiotics for longer than 3 days in the overall population, even with negative antimicrobial cultures, full enteral feeding, and stability in room air. In both groups, 18.7 and 15.6% of patients, respectively, were treated for 4 to 6 days, a nontraditional duration of therapy. A total of 116 infants (11.6%) were treated for 7 to 10 days in both groups combined. Although there was a slight trend in the risk factor group towards longer treatment, it was not statistically significant (p ¼ 0.15). Table 3 demonstrates differences in practice management in five marketplace regions in which ParadigmHealth oversees the care of neonatal patients. Four of the regions demonstrated consistency in antibiotic use, while both the duration of antibiotic therapy and the length of stay were significantly longer in the infants treated in Region I, increasing mean length of stay by approximately 1.8 days ( p<0.05).
DISCUSSION
The results of this study suggest that the decision to treat infants admitted for suspected neonatal sepsis with antibiotics and the duration of therapy are not always founded upon either strong evidence-based practice or readily identifiable clinical factors. Infants with no maternal risk for sepsis appear to be treated as often and for the same duration of time as situations in which multiple risk factors are noted to be present at birth. The duration of therapy for suspected, but not proven, sepsis lasts approximately 2 to 3 days in most cases, but extends to 10 days for some patients, while a significant number of neonates are treated for 4 to 6 days, a nontraditional and questionable duration of treatment. The reasons for these variable and sometimes protracted courses of therapy appear to be based upon considerations other than just maternal risk factors or the clinical presentation of the patient. In all cases, since infants had to be in room air and orally feeding by 24 hours of life without other confounding diagnoses for inclusion in this database review, the physical appearance of the patient did not seem to be the main contributing factor in the decision for continued antibiotic therapy.
This study raises the question of why treatment is continued for an extended period of time in so many infants. In some instances, it appeared that there was a simple, but costly, oversight in neglecting to write an order to discontinue antibiotic therapy. The prior experience of the practicing neonatologist was probably also a deciding factor. Most neonatologists have treated an infant whose There were no statistical differences between infants in either the no risk or risk with respect to duration of treatment.
symptoms appeared minimal shortly after birth, and who were then subsequently overwhelmed by a serious neonatal infection. At the peak of the GBS era, from the mid-1970's to the mid-1980s, it was not at all uncommon to examine a neonate shortly after birth who appeared clinically well, only to have that same infant die within 24 to 48 hours. Even with early institution of aggressive antibiotic therapy, these patients could not be rescued in some cases and succumbed to overwhelming GBS infection. The memory of such patients is not easily erased, and may contribute to the anxiety that many physicians experience when confronted by an infant who initially may be at risk for sepsis.
The neonate also imposes a number of limitations on the diagnostic skills of even the best practitioner, because of the relatively modest scope of responses that an infant has to a wide variety of problems. Term infants who manifest tachypnea shortly after birth may have delayed reabsorption of fetal lung fluid or transient tachypnea, neonatal pneumonia, meconium aspiration syndrome, persistent pulmonary hypertension, respiratory distress syndrome (still occasionally present in near-term infants) or neonatal septicemia, to name but a few of the common possible diagnoses. Even chest radiographs may not immediately reveal the correct diagnosis, and prudent neonatologists often attempt to treat as many of these possible diagnoses as they can, in order to limit disease progression. Since neonatal septicemia is one of the disease processes most amenable to treatment, especially when instituted early, antibiotic coverage in such cases reflects a common and appropriate standard of care.
It is not the fact that antibiotics are started that is the central issue illustrated by this report, however, but that they sometimes are continued for variable and prolonged periods of time. Recent evidence strongly suggests that it is highly unlikely that a child has a serious blood-born infection when cultures are negative after 36 hours, assuming that an adequate blood volume (1 ml or greater) was obtained when blood cultures were drawn. 5 Furthermore, when definite bacterial pathogens are present, Kumar et al., 6 have shown that not only are most cultures likely to become positive by 36 hours, but that the probability that a negative culture at 36 hours will remain negative is 99.8%. The evidence that exists, therefore, would argue that properly obtained cultures are highly reliable and valid in terms of the diagnosis of true septicemia in the neonate. Furthermore, in a two-site prospective trial of culture diagnosis from our institution, it was shown that for early neonatal sepsis, a single early 1 ml culture is adequate for diagnosis. 7 It would therefore appear that there is a high degree of culture reliability in diagnosing sepsis that seems to be disregarded by many physicians, who frequently continue to treat beyond 2 to 3 days. Although the Factors that were not examined in this study were the initial white blood cell count and differential, or acute phase reactions such as CRP, which many neonatologists believe to be important in diagnosing neonatal sepsis. Schelonka et al. 8 have examined normal neutrophil indices in healthy term infants, examining immature to mature cells, in particular, as a means for assisting in the diagnosis of sepsis. Kocherlakota, 9 however, has shown that white cell counts can be depressed in certain clinical situations (e.g., neutropenia from intrauterine growth retardation) in the absence of sepsis. From animal studies, it also appears that maternal events may modulate neonatal white blood cell production, even when no infection is present in the offspring. 10 Since many studies during the past decade have illustrated a role for elevated cytokines in both mother and fetus in noninfectious situations (i.e., maternal epidural anesthesia), the clinician needs to be aware that what may initially be interpreted as appear to be sepsis may actually be a generalized cytokine effect with associated transient elevation of acute phase reactants, in the absence of negative cultures. 11 Furthermore, investigators have found similar types of acute metabolic responses in septic and nonseptic neonates with elevated IL-6, IL-8, and CRP levels, even in the absence of bacteremia in their study patients. 12 Thus, it would appear that while white cell levels and indices may assist with the diagnosis of sepsis, the gold standard remains a positive blood culture, which is virtually always positive in the presence of true bloodstream infection by 36 hours of life. This gold standard, however, was not observed in any of the 998 infants included in this study, yet antibiotic therapy was often used for periods between 4 and 10 days.
It is therefore evident from these results that neonatologists commonly make the decision to use antibiotics on factors other than positive blood cultures. Examination of the reasons for this practice, especially when antimicrobial therapy is used for extended periods in essentially well infants, needs to be seriously reconsidered. Protracted, unnecessary therapy may lead to increased resistance of microorganisms in nurseries and have grave consequences for future generations of neonates.
